Contact the ACC Registration and Housing Center

  • (888) 322-2878
    (toll-free)
  • (847) 996-5822 (International)
  • M-F, 9:00 a.m. - 6:00 p.m. ET
  • acc@experient-inc.com
  • Innovation Stage
    Expo Hall, #23012

    Looking for something different? Check out ACC's Innovation Stage — a unique theater that provides and opportunity to enjoy a 30-minute focused discussion in a relaxed setting.

      Saturday, March 28
      Saturday, March 28

    9:45 a.m. – 10:15 a.m.

    4201. What You Need to Know About the Latest Generation of MitraClip™ G4: Case Based Discussion
    Sponsored by Abbott

    Learn about the latest advancement in Transcather Mitral valve repair(TMVr) procedure and how to effectively manage and treat patients with MitraClip™ G4. Join us as our expert faculty present a comprehensive overview of treating patients who may be candidates for TMVr.

    Speakers:
    Saibal Kar, MD, FACC, FSCAI
    Director of Structural Heart Disease and Research
    HCA Healthcare, Los Angeles, CA

    Paul Sorajja, MD, FACC, FAHA, FSCAI
    Director, Center of Valve and Structural Heart Disease
    Minneapolis Heart Institute, Minneapolis, MN

    10:45 a.m. – 11:15 a.m.

    4202. Evidence-Based Approach to Anticoagulation Therapy for Chronic CAD/PAD
    Sponsored by Janssen Pharmaceuticals, Inc.

    Patients with chronic coronary artery disease (CAD) or peripheral artery disease (PAD) are at risk for major cardiovascular events, including cardiovascular death, myocardial infarction, and stroke. Join us for a presentation describing an approach to reducing the risk of these events.

    Speaker:
    Matthew Charles Becker, MD, FACC, FSCAI, FSVM

    12:30 p.m. – 1:00 p.m.

    4203. Evidence-Based Approach to Anticoagulation for NVAF
    Sponsored by Janssen Pharmaceuticals, Inc.

    This lecture will present options for reducing the risk of stroke in patients with nonvalvular atrial fibrillation (NVAF).

    Speaker:
    Dharmesh Patel, MD, MBBS (London), FACC, FACP, FASPC, FNLA

    1:30 p.m. – 2:00 p.m.

    4204. Evidence-Based Approach to Anticoagulation Therapy for Chronic CAD/PAD
    Sponsored by Janssen Pharmaceuticals, Inc.

    Patients with chronic coronary artery disease (CAD) or peripheral artery disease (PAD) are at risk for major cardiovascular events, including cardiovascular death, myocardial infarction, and stroke. Join us for a presentation describing an approach to reducing the risk of these events.

    Speaker:
    Sandeep Nathan, MD, MSc

    3:45 p.m. – 4:15 p.m.

    4205. Stop the Progression: Advances in the Treatment of Atrial Fibrillation
    Sponsored by Biosense Webster, Inc.

    Learn about the latest advances in AFib treatment options and how to effectively manage and treat AFib patients.

    Speaker:
    Dhanunjaya Lakkireddy, MD

      Sunday, March 29
      Sunday, March 29

    9:45 a.m. – 10:15 a.m.

    4206. The Unmet Medical Need in HFrEF: Current Challenges and Future Opportunities
    Sponsored by Medscape

    12:30 p.m. – 1:00 p.m.

    4207. What Fails in Heart Failure? A Look at the Myocardium
    Sponsored by Amgen

    Speaker:
    Mitchell Psotka, MD, PhD

    1:30 p.m. – 2:00 p.m.

    4208. Patient Stands Up, Blood Pressure Goes Down: Diagnostic and Management Considerations for Symptomatic Neurogenic Orthostatic Hypotension
    Sponsored by Lundbeck

    A lively dual presentation between a Cardiologist and Neurologist on the identification and management of patients with orthostatic hypotension caused by dysautonomia — also known as neurogenic orthostatic hypotension (nOH). Presentation will include a brief overview of nOH and its symptoms, diagnostic and management considerations, and a Q&A with the audience.

    Speakers
    Fahd Amjad, MD, MS

    Sean Beinart, MD, FACC, FHRS

    3:45 p.m. – 4:15 p.m.

    4209. I'm Afraid to Faint Again: Overview of Neurogenic Orthostatic Hypotension Diagnosis and Management
    Sponsored by Lundbeck

    This disease state education presentation provides an overview of orthostatic hypotension caused by dysautonomia — also known as neurogenic orthostatic hypotension (nOH). Learn more about the associated symptoms of nOH, as well as diagnostic and management considerations.

    Speaker
    Brian Olshansky, MD

      Monday, March 30
      Monday, March 30

    9:45 a.m. – 10:15 a.m.

    4210. Contrast Induced Acute Kidney Injury Reduction in the Cath Lab: Protocol Development, Implementation, and Outcomes
    Sponsored by Osprey Medical

    Contrast-Induced AKI is strongly associated with morbidity, mortality, and significantly increased health-care expenses. Implementation of Cath Lab based Kidney Care Protocols have proven that AKI reduction is possible. Please join us to learn about one of those experiences and how they are protecting their Cath Lab patients from AKI.

    Speaker:
    Barry Bertolet, MD
    North Mississippi Medical Center, Tupelo, MS

    12:30 p.m. – 1:00 p.m.

    4211. Implications of Hyperkalemia on RAASi Therapy in Patients With HFrEF
    Sponsored by AstraZeneca Pharmaceuticals LP

    The session will review recommendations in clinical practice guidelines for renin-angiotensin-aldosterone system inhibition (RAASi) therapy in heart failure; the prevalence of hyperkalemia associated with RAASi therapy in patients with heart failure and the extent of RAASi down-titration or discontinuation as a treatment strategy; the impact of suboptimal RAASi therapy on patient morbidity, mortality and healthcare burden; and discuss balancing RAASi therapy and hyperkalemia. Dr. Peter McCullough will explore the issue of managing hyperkalemia and the best approaches with elaboration and perspective.

    Speaker:
    Peter A. McCullough, MD, MPH, FACC, FACP, FAHA, FCCP, FNKF, FCRSA


    Schedule is current as of Feb. 12, 2020, and is subject to change. Please check back for updates.

    *Innovation Stage presentations are not part of ACC.20/WCC, as planned by its Program Committee, and do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.

    ADVERTISEMENT
    Have a question about ACC.20/WCC?
    Ask Artie, our show expert chatbot.
    ACC Logo
    ACC.20/WCC on Social Media:
          
    2019 American College of Cardiology Foundation. Visit ACC.org
    Terms and Conditions Registered User Agreement Advertising and Sponsorship Policy Privacy Policy Cookie Policy Contact Us